Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$180,005,554
+$30,502,384 QoQ
Shares Held
708,767
+15.9% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#216
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $468,870,808 across 14 Drug Manufacturers - General names. JNJ ranks #1 (38.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
708,767 | $180,005,554 | |
| 2 | LLY |
ELI LILLY & Co
|
96,123 | $115,292,819 | |
| 3 | ABBV |
AbbVie Inc.
|
297,328 | $74,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
282,377 | $36,285,444 | |
| 5 | AMGN |
Amgen Inc
|
70,291 | $25,453,776 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
113,192 | $14,300,677 | |
| 7 | NVS |
Novartis AG
|
38,592 | $6,048,138 | |
| 8 | PFE |
Pfizer Inc
|
247,206 | $5,952,720 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $180,005,554 | 708,767 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $149,503,170 | 611,615 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $129,847,052 | 627,432 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $88,614,552 | 580,128 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $93,297,603 | 562,576 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $78,722,161 | 544,338 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $88,277,161 | 544,719 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $73,108,208 | 500,193 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $74,531,851 | 471,154 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $71,946,638 | 459,019 | Shares | Sole | 2024-02-28 | |
| 2023-09-30 | $70,528,428 | 452,831 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | $971,767 | 5,871 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,785,475 | 114,745 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $69,448,887 | 393,144 | Shares | Sole | 2023-06-12 | |
| 2022-09-30 | $63,695,697 | 389,910 | Shares | Sole | 2022-12-02 | |
| 2022-06-30 | $62,557,896 | 352,419 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $60,761,710 | 342,841 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $56,728,351 | 331,609 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $51,310,649 | 317,713 | Shares | Sole | 2021-11-23 | |
| 2021-06-30 | $51,586,683 | 313,140 | Shares | Sole | 2021-08-24 | |
| 2021-03-31 | $49,395,063 | 300,548 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $44,424,754 | 282,277 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $39,099,312 | 262,623 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $35,243,846 | 250,614 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $32,263,356 | 246,041 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||